Insider filing · SLNO

Bhatnagar Anish sold $47.2M of Soleno Therapeutics (SLNO)

Executed Mar 27 2025, disclosed Mar 31 2025, 4 days later.

Returns are measured on stock purchases only.

BA Bhatnagar Anish CHIEF EXECUTIVE OFFICER profile →

Bhatnagar Anish (CHIEF EXECUTIVE OFFICER) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in SLNO. The largest single filing was $47.2M of SLNO (698,363 sh across 11 lots, as filed), executed Mar 27 2025.

SLNO SLNO SLNO · 19 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→